Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 4/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30264868 | 0.94 | IL23R (0.56) | IL23R | |
| SCHEMBL31184624 | 0.94 | ACE (0.55) | ACEECE1 | |
| SCHEMBL29476594 | 0.94 | ACE (0.55) | ACEECE1 | |
| SCHEMBL29511163 | 0.94 | ACE (0.55) | ACEECE1 | |
| SCHEMBL29816188 | 0.94 | IL23R (0.53) | IL23R | |
| SCHEMBL30028924 | 0.93 | BMP1 (0.51) | ACEECE1 | |
| SCHEMBL29511259 | 0.93 | BMP1 (0.51) | ACEECE1 | |
| SCHEMBL29511016 | 0.93 | OPRM1 (0.56) | OPRM1OPRD1IL23R | |
| SCHEMBL30264918 | 0.92 | IL23R (0.54) | OPRD1IL23R | |
| SCHEMBL30866237 | 0.91 | NPBWR1 (0.55) | OPRM1OPRD1PRMT1IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2026-03-26 | — | — | US | disclosed |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | THRB, MC1R, MC5R | ACE 3407/4885OPRM1 25/4885OPRD1 19/4885 |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | MC3R, MC1R, MC5R | ACE 3249/4885OPRM1 115/4885OPRD1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.